Nodule TI-RADS classification on ThyroidXL (3-fold cross-val)
64.67PrecisionClinically Guided
Evaluation Results
| Method | Links | |||
|---|---|---|---|---|
| Clinically GuidedLearning paradigm=multitask, Evaluation protocol=3-fold cross-validation2026.03 | 64.67 | 62 | 62.67 | |
| +RLARLearning paradigm=multitask, Evaluation protocol=3-fold cross-validation2026.03 | 63 | 61 | 61.33 | |
| +Rep-MTLLearning paradigm=multitask, Evaluation protocol=3-fold cross-validation2026.03 | 62.33 | 62 | 61.67 | |
| Vanilla MultitaskLearning paradigm=multitask, Evaluation protocol=3-fold cross-validation2026.03 | 61.3 | 60 | 60 | |
| EfficientNet B7Learning paradigm=single-task, Evaluation protocol=3-fold cross-validation2026.03 | 57.5 | 57 | 56.1 | |
| ConvNeXtLearning paradigm=single-task, Evaluation protocol=3-fold cross-validation2026.03 | 48.22 | 44.52 | 41.36 |